Clinical Trials Directory

Trials / Completed

CompletedNCT03433768

Androgen Receptor mRNA Expression is Positively Associated With Live Birth in Women Undergoing IVF Independently of the Type of Ovarian Response

Androgen Receptor (AR) mRNA Expression is Positively Associated With Live Birth in Women Undergoing In-vitro Fertilization Independently of the Type of Ovarian Response

Status
Completed
Phase
Study type
Observational
Enrollment
67 (actual)
Sponsor
Aristotle University Of Thessaloniki · Academic / Other
Sex
Female
Age
20 Years – 42 Years
Healthy volunteers

Summary

AR is a steroid hormone receptor that regulates various genes' expression and affects cellular proliferation and differentiation. Androgens interact with AR, exert their paracrine action on granulosa cells and regulate gonadotropin synthesis, follicle development, oocyte maturation and corpus luteum function. Estrogens increase AR mRNA and testosterone binding site in uterine endometrium and leiomyoma. In human cancer cells, low estradiol increases AR levels, suggesting the estrogen/androgen ratio as a predictor of sex steroid response. AR mRNA expression is, also, regulated by progesterone. Although AR mRNA is expressed in the female reproductive tissues, its expression has never been studied in peripheral blood.

Conditions

Interventions

TypeNameDescription
GENETICReal time PCRWe take peripheral blood sample at day one, six and ten of ovarian stimulation and measure mRNA expression of androgen receptor.

Timeline

Start date
2014-09-14
Primary completion
2017-10-10
Completion
2018-01-10
First posted
2018-02-15
Last updated
2018-02-15

Source: ClinicalTrials.gov record NCT03433768. Inclusion in this directory is not an endorsement.